In vitro genotoxicity testing using the micronucleus assay in cell lines, human lymphocytes and 3D human skin models

Mutagenesis

Volumn 26, Issue 1, 2011, Pages 177-184

  Kirsch Volders, Micheline ^a   Decordier, Ilse ^a   Elhajouji, Azeddine ^b   Plas, Gina ^a   Aardema, Marilyn J ^c   Fenech, Michael ^d  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^b NOVARTIS PHARMA AG   (Switzerland)

^c Marilyn Aardema Consulting LLC   (United States)

^d CSIRO   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; COSMETIC;

CELL AGING; CELL LINE; CONTROLLED STUDY; CYTOKINESIS; FALSE NEGATIVE RESULT; GENOTOXICITY; HUMAN; HUMAN CELL; LYMPHOCYTE; MICRONUCLEUS TEST; MODEL; MUTAGENICITY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SKIN;

CELL LINE; DNA DAMAGE; HUMANS; LYMPHOCYTES; MICRONUCLEUS TESTS; MUTAGENS; ORGAN CULTURE TECHNIQUES; SKIN;

EID: 78650657632     PISSN: 02678357     EISSN: 14643804     Source Type: Journal    
DOI: 10.1093/mutage/geq068     Document Type: Review

References (75)

1. Elston, R. N. (1963) Nuclear budding and MN formation in human bone marrow, skin and fascia lata cells in vitro and in oral mucosa cells in vivo. Acta Pathol. Microbiol. Scand., 59, 195-199.
2. Countryman, P. I. and Heddle, J. A. (1976) The production of MN from chromosome aberrations in irradiated cultures of human lymphocytes. Mutat. Res., 41, 321-332.
3. Fenech, M. and Morley, A. (1985) Solutions to the kinetic problem in the micronucleus assay. Cytobios., 43, 233-246.
4. Fenech, M. and Morley, A. A. (1986) Cytokinesis-block micronucleus method in human lymphocytes: effect of in vivo ageing and low dose X-irradiation. Mutat. Res., 161, 193-198.
5. OECD (draft). In Vitro Mammalian Cell Micronucleus Test (MNvit). OECD Guideline for Testing of Chemicals No. 487. OECD, Paris. http:// www.oecd.org/env/testguidelines (date last accessed September 28, 2010).
6. Kirsch-Volders, M., Sofuni, T., Aardema, M. et al. (2000) Report from the in vitro micronucleus assay working group. Environ. Mol. Mutagen., 35, 167-172.
7. Kirsch-Volders, M., Sofuni, T., Aardema, M. et al. (2003) Report from the in vitro micronucleus assay working group. Mutat. Res., 540, 153-163.
8. Lorge, E., Thybaud, V., Aardema, M. J., Oliver, J., Wakata, A., Lorenzon, G. and Marzin, D. (2006) SFTG international collaborative study on in vitro micronucleus test I. General conditions and overall conclusions of the study. Mutat. Res., 607, 13-36. (Pubitemid 44026678)
9. Oliver, J., Meunier, J. R., Awogi, T. et al. (2006) SFTG international collaborative study on in vitro micronucleus test V. Using L5178Y cells. Mutat. Res., 607, 125-152.
10. Aardema, M. J., Snyder, R. D., Spicer, C. et al. (2006) SFTG international collaborative study on in vitro micronucleus test III. Using CHO cells. Mutat. Res., 607, 61-87.
11. Wakata, A., Matsuoka, A., Yamakage, K. et al. (2006) SFTG international collaborative study on in vitro micronucleus test IV. Using CHL cells. Mutat. Res., 607, 88-124.
12. Clare, M. G., Lorenzon, G., Akhurst, L. C. et al. (2006) SFTG international collaborative study on in vitro micronucleus test II. Using human lymphocytes. Mutat. Res., 607, 37-60. (Pubitemid 44055922)
13. Hartung, T., Bremer, S., Casati, S. et al. (2004) A modular approach to the ECVAM principles on test validity. Altern. Lab. Anim., 32, 467-472.
14. Corvi, R., Albertini, S., Hartung, T., Hoffmann, S., Maurici, D., Pfuhler, S., van Benthem, J. and Vanparys, P. (2008) ECVAM retrospective validation of in vitro micronucleus test (MNT). Mutagenesis, 23, 271-83.
15. ECVAM. (2006) Statement by the European Centre for the Validation of Alternative Methods (ECVAM) Scientific Advisory Committee (ESAC) on the Scientific Validity of the In vitro Micronucleus Test as an Alternative to the In vitro Chromosome Aberration Assay for Genotoxicity Testing. ESAC 25th meeting, November 16-17, 2006. http://ecvam.jrc.it/index.htm (date last accessed September 28, 2010).
16. ESAC. (2006) ECVAM Scientific Advisory Committee (ESAC) Peer Review. Retrospective Validation of the In Vitro Micronucleus Test. Summary and Conclusions of the Peer Review Panel. European Centre for the Validation of Alternative Methods (ECVAM), Ispra, Italy November. 16-17, 2006, http:// ecvam.jrc.it/index.htm (date last accessed September 28, 2010).
17. Bonassi, S., El-Zein, R., Barale, R. and Fenech, M. (2010) Associations of micronucleus frequency with cancer risk. Mutagenesis, 26, 93-100.
18. Decordier, I., Papine, A., Vande Loock, K., Plas, G., Soussaline, F. and Kirsch-Volders, M. (2010) Automated image analysis of MN by IMSTAR for biomonitoring. Mutagenesis, 26, 163-168.
19. Elhajouji, A., Cammerer, Z., Lukamowicz, M. and Kirsch-Volders, M. (2010) Potential thresholds for genotoxic effects by MN scoring. Mutagenesis, 26, 199-204.
20. Hayashi, M., MacGregor, J. T., Gatehouse, D. G. et al. (2007) In Vivo Micronucleus Assay Working Group, IWGT. In vivo erythrocyte micronucleus assay III. Validation and regulatory acceptance of automated scoring and the use of rat peripheral blood reticulocytes, with discussion of non-hematopoietic target cells and a single dose-level limit test. Mutat. Res., 627, 10-30.
21. Dertinger, S., Bryce, S., Avlasevich, S., De Boeck, M., Van Goethem, F., Elhajouji, A., Nicolette, J., Shi, J. and Lynch, A. (2010) Flow cytometry for automated micronucleus assay in cultured nucleated cells. Mutagenesis, 26, 147-152.
22. Elhajouji, A., Cunha, M. and Kirsch-Volders, M. (1998) Spindle poisons can induce polyploidy by mitotic slippage and micronucleate mononu-cleates in the cytokinesis-block assay. Mutagenesis, 13, 193-198.
23. Fenech, M. (2000) A mathematical model of the in vitro micronucleus assay predicts false negative results if MN are not specifically scored in binucleated cells or in cells that have completed one nuclear division. Mutagenesis, 15, 329-336.
24. Norppa, H., Renzi, L. and Lindholm, C. (1993) Detection of whole chromosomes in MN of cytokinesis-blocked human lymphocytes by antikinetochore staining and in situ hybridization. Mutagenesis, 8, 519-525. (Pubitemid 23344984)
25. Gonzalez, L., Thomassen, L., Rabolli, V. et al. Adaptations of the MN assay for the genotoxicity assessment of insoluble nanoparticles. Mutagenesis, 26, 185-191.
26. Lorge, E., Hayashi, M., Albertini, S. and Kirkland, D. (2008) Comparison of different methods for an accurate assessment of cytotoxicity in the in vitro micronucleus test. I. Theoretical aspects. Mutat. Res., 655, 1-3.
27. Kirkland, D. (eds) (2010) Collaborative evaluation of the toxicity measures recommended in the draft OECD Test Guideline 487 on the In vitro Mammalian Cell Micronucleus Test (MNvit). Mutat. Res., in press.
28. Fenech, M. (2007) Cytokinesis-block micronucleus cytome assay. Nat. Protoc., 2, 1084-1104.
29. Van Hummelen, P. and Kirsch-Volders, M. (1990) An improved method for the 'in vitro' micronucleus test using human lymphocytes. Mutagenesis, 5, 203-204.
30. Elhajouji, A., Santos, A. P., Van Hummelen, P. and Kirsch-Volders, M. (1994) Metabolic differences between whole blood and isolated lymphocyte cultures for micronucleus (MN) induction by cyclophosphamide and benzo[a]pyrene. Mutagenesis, 9, 307-313. (Pubitemid 24221312)
31. Högstedt, B. (1984) MN in lymphocytes with preserved cytoplasm. A method for assessment of cytogenetic damage in man. Mutat. Res., 130, 63-72.
32. Maki-Paakanen, J. and Norppa, H. (1987) Induction of MN by vinyl acetate in mouse bone marrow cells and cultured lymphocytes. Mutat. Res., 190, 41-45.
33. Thomson, E. J. and Perry, P. E. (1988) The identification of micronucleated chromosomes: a possible assay for aneuploidy. Mutagenesis, 3, 415-418.
34. Tates, A. D., Van Welie, M. T. and Ploem, J. S. (1990) The present state of the automated micronucleus test for lymphocytes. Int. J. Radiat. Biol., 58, 813-825.
35. Surrallés, J., Carbonell, E., Marcos, R., Degrassi, F., Antoccia, A. and Tanzarella, C. (1992) A collaborative study on the improvement of the micronucleus test in cultured human lymphocytes. Mutagenesis, 7, 407-410.
36. Darroudi, F., Meijers, C. M., Hadjidekova, V. and Natarajan, A. T. (1996) Detection of aneugenic and clastogenic potential of X-rays, directly and indirectly acting chemicals in human hepatoma (Hep G2) and peripheral blood lymphocytes, using the micronucleus assay and fluorescent in situ hybridization with a DNA centromeric probe. Mutagenesis, 11, 425-433.
37. Kirsch-Volders, M., Sofuni, T., Aardema, M. et al. (2004) Corrigendum to ''Report from the in vitro micronucleus assay working group''(Mutat. Res., 540, 153-163). Mutat. Res., 564, 97-100.
38. Van Hummelen, P., Elhajouji, A. and Kirsch-Volders, M. (1995) Clastogenic and aneugenic effects of three benzimidazole derivates in the in vitro micronucleus test on human lymphocytes determined with FISH using a centromeric probe. Mutagenesis, 10, 23-29.
39. Elhajouji, A., Tibaldi, F. and Kirsch-Volders, M. (1997) Indication for thresholds of chromosome non-disjunction versus chromosome lagging induced by spindle inhibitors in vitro in human lymphocytes. Mutagenesis, 12, 133-140.
40. Vian, L., Bichet, N. and Gouy, D. (1993) The in vitro micronucleus test on isolated human lymphocytes. Mutat. Res., 291, 93-102.
41. Jantunen, K., Mäki-Paakkanen, J. and Norppa, H. (1986) Induction of chromosome aberrations by styrene and vinylacetate in cultured human lymphocytes: dependence on erythrocytes. Mutat. Res., 159, 109-116.
42. Fenech, M., Chang, W. P., Kirsch-Volders, M., Holland, N., Bonassi, S. and Zeiger, E. (2003) HUman MicronNucleus project. HUMN project: detailed description of the scoring criteria for the cytokinesis-block micronucleus assay using isolated human lymphocyte cultures. Mutat. Res., 534, 65-75.
43. Kirkland, D. (2010) Evaluation of different cytotoxic and cytostatic measures for the in vitro micronucleus test (MNVit): introduction to the collaborative trial. Mutat. Res., in press.
44. Zhang, L. S., Honma, M., Hayashi, M., Suzuki, T., Matsuoka, A. and Sofuni, T. (1995) A comparative study of TK6 human lymphoblastoid and L5178Y mouse lymphoma cell lines in the in vitro micronucleus test. Mutat. Res., 347, 105-115.
45. Ehrlich, V., Darroudi, F., Uhl, M., Steinkellner, S., Zsivkovits, M. and Knasmeuller, S. (2002) Fumonisin B1 is genotoxic in human derived hepatoma (HepG2) cells. Mutagenesis, 17, 257-260.
46. Knasmüller, S., Mersch-Sundermann, V., Kevekordes, S., Darroudi, F., Huber, W. W., Hoelzl, C., Bichler, J. and Majer, B. J. (2004) Use of human-derived liver cell lines for the detection of environmental and dietary genotoxicants; current state of knowledge. Toxicology, 198, 315-328.
47. Gibson, D. P., Brauninger, R., Shaffi, H. S., Kerckaert, G. A., LeBoeuf, R. A., Isfort, R. J. and Aardema, M. J. (1997) Induction of micronuclei in Syrian hamster embryo cells: comparison to results in the SHE cell transformation assay for National Toxicology Program test chemicals. Mutat. Res., 392, 61-70.
48. Decordier, I., Cundari, E. and Kirsch-Volders, M. (2005) Influence of caspase activity on micronuclei detection: a possible role for caspase-3 in micronucleation. Mutagenesis, 20, 173-179.
49. Majer, B. J., Mersch-Sundermann, V., Darroudi, F., Laky, B., de Wit, K. and Knasmüller, S. (2004) Genotoxic effects of dietary and lifestyle related carcinogens in human derived hepatoma (HepG2, Hep3B) cells. Mutat. Res., 551, 153-166.
50. Singh, J., Reen, R. K. and Wiebel, F. J. (1994) Piperine, a major ingredient of black and long peppers, protects against AFB1-induced cytotoxicity and micronuclei formation in H4IIEC3 rat hepatoma cells. Cancer Lett., 86, 195-200.
51. Eckl, P. M. and Raffelsberger, I. (1997) The primary rat hepatocyte micronucleus assay: general features. Mutat. Res., 392, 117-124.
52. Kirkland, D., Pfuhler, S., Tweats, D. et al. (2007) How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-up animal tests: Report of an ECVAM Workshop. Mutat. Res., 628, 31-55.
53. Curren, R. D., Mun, G. C., Gibson, D. P. and Aardema, M. J. (2006) Development of a method for assessing micronucleus induction in a 3D human skin model (EpiDerm). Mutat. Res., 607, 192-204.
54. Mun, G. C., Aardema, M. J., Hu, T., Barnett, B., Kaluzhny, Y., Klausner, M., Karetsky, V., Dahl, E. L. and Curren, R. D. (2009) Further development of the EpiDerm 3D reconstructed human skin micronucleus (RSMN) assay. Mutat. Res., 673, 92-99.
55. EU Directive 2003/15/EC of the European Parliament and the Council of 27 February 2003 amending Council Directive 76/768/EEC on the approximation of the laws of the Members States relating to cosmetic products. Official J. Eur Union, L66, 26-35.
56. European Commission (2006) Regulation (EC) No. 1907/2006 of the European Parliament and of the Council of 18 December 2006 Concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACh), Establishing a European Chemicals Agency, Amending Directive 1999/45/EC and Repealing Council Regulation (EEC) No. 793/93 and Commission Regulation (EC) No. 1488/94 as well as Council Directive 76/ 769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC. http://eur-lex.europa.eu/LexUriServ/ LexUriServ.do? uri5CELEX:32006R1907:EN: NOT (date last accessed September 28, 2010).
57. Speit, G. (2009) How to assess the mutagenic potential of cosmetic products without animal tests? Mutat. Res., 678, 108-112.
58. SCCP/1212/09 (2009) Position Statement on Genotoxicity/Mutagenicity Testing of Cosmetic Ingredients without Animal Experiments. http:// ec.europa.eu/health/ph-risk/committees/04-sccp/docs/sccp-s-08.pdf (date last accessed September 28, 2010).
59. Gibbs, S., van de Sandt, J. J., Merk, H. F., Lockley, D. J., Pendlington, R. U. and Pease, C. K. (2007) Xenobiotic metabolism in human skin and 3D human skin reconstructs: a review. Curr. Drug Metab., 8, 758-772.
60. Oesch, F., Fabian, E., Oesch-Bartlomowicz, B., Werner, C. and Landsiedel, R. (2007) Drug-metabolizing enzymes in the skin of man, rat, and pig. Drug Metab. Rev., 39, 659-698.
61. Hu, T., Bailey, R. E., Morrall, S. W., Aardema, M. J., Stanley, L. A. and Skare, J. A. (2009) Dermal penetration and metabolism of p-aminophenol and p-phenylenediamine: application of the EpiDerm human reconstructed epidermis model. Toxicol. Lett., 188, 119-129.
62. Nohynek, G. J., Skare, J. A., Meuling, W. J. A., Hein, D. W., Bie, A. and Toutain, H. (2004) Urinary acetylated metabolites and N-acetyltransferase-2 genotype in human subjects treated with a para-phenylenediamine-containing oxidative hair dye. Food Chem. Toxicol., 42, 1885-1891.
63. Nohynek, G. J., Duche, D., Garrigues, A., Meunier, P. A., Toutain, H. and Leclaire, J. (2005) Under the skin: biotransformation of para-aminophenol and para-phenylenediamine in reconstructed human epidermis and human hepatocytes. Toxicol. Lett., 158, 196-212.
64. Hu, T., Khambatta, Z. S., Hayden, P. J. et al. (2010) Xenobiotic metabolism gene expression in an in vitro 3D Human Epidermal Model compared to human skin. Toxicol. In Vitro, 24, 1450-1463.
65. Flamand, N., Marrot, L., Belaidi, J.-P., Bourouf, L., Dourille, E., Feltes, M. and Meunier, J. R. (2006) Development of genotoxicity test procedures with EpiskinR, a reconstructed skin model: towards new tools for in vitro risk assessment of dermally applied compounds? Mutat. Res., 606, 39-51.
66. Hu, T., Kaluzhny, Y., Mun, G. C, Barnett, B., Karetsky, V., Wilt, N., Klausner, M., Curren, R. D. and Aardema, M. J. (2009) Intralaboratory and interlaboratory evaluation of the EpiDerm 3D human reconstructed skin micronucleus (RSMN) assay. Mutat. Res., 673, 100-108.
67. Aardema, M. J., Barnett, B., Khambatta, Z. et al. (2010) International validation of the EpiDerm™ 3D Human Reconstructed Skin Micronucleus (RSMN) Assay: transferability and reproducibility. Mutat. Res., http:// dx.doi.org/10.1016/j.mrgentox.2010.05.017.
68. Pfuhler, S., Kirst, A., Aardema, M. J. et al. (2010) A tiered approach to the use of alternatives to animal testing for the safety assessment of cosmetics: Genotoxicity. A COLIPA analysis. Mut. Res., in press.
69. Elhajouji, A., Van Hummelen, P. and Kirsch-Volders, M. (1995) Indications for a threshold of chemically-induced aneuploidy in vitro in human lymphocytes. Environ. Mol. Mutagen., 26, 292-304.
70. Furness, D., Hague, W., Khong, Y., Dekker, G. and Fenech, M. (2010) Increased lymphocyte micronucleus frequency in early pregnancy is associated prospectively with pre-eclampsia and/or intrauterine growth restriction. Mutagenesis, in press.
71. Murgia, E., Ballardin, M., Bonassi, S., Rossi, A. M. and Barale, R. (2008) Validation of MN frequency in peripheral blood lymphocytes as early cancer risk biomarker in a nested case-control study. Mutat. Res., 639, 27-34.
72. Murgia, E., Maggini, V., Barale, R. and Rossi, A. M. (2007) MN, genetic polymorphisms and cardiovascular disease mortality in a nested case-control study in Italy. Mutat. Res., 621, 113-118.
73. Federici, C, Botto, N., Manfredi, S., Rizza, A., Del Fiandra, M. and Andreassi, M. G. (2008) Relation of increased chromosomal damage to future adverse cardiac events in patients with known coronary artery disease. Am. J. Cardiol., 102, 1296-1300.
74. Bonassi, S., Znaor, A., Ceppi, M. et al. (2007) An increased micronucleus frequency in peripheral blood lymphocytes predicts the risk of cancer in humans. Carcinogenesis, 28, 625-631.
75. Fenech, M., Kirsch-Volders, M., Natarajan, A. T. et al. (2010) Molecular mechanisms of micronucleus, nucleoplasmic bridge and nuclear bud formation in mammalian and human cells. Mutagenesis, 26, 125-132.